The Botanix Pharmaceuticals Ltd ( ASX: BOT ) share price is having a day to forget on Monday.
In afternoon trade, the ASX 300 stock is down 18% to 38.2 cents.
Why is this ASX 300 stock crashing?
Investors have been selling Botanix and other healthcare shares today amid concerns over US President Donald Trump's plans to cut the price of prescriptions.
According to Reuters , Trump plans to sign an executive order to cut prescription prices to the level paid by other high-income countries. He estimates that this could be a discount of 30% to 80% from current prices.
The US reportedly pays the most in the world for many prescription drugs. In some cases it can be nearly triple that of what people are paying in other developed nations.
Given its big decline, the ASX 300 stock was briefly paused from trade while it prepared a response to the speculation.
The good news is that it feels that it should be safe from any price pressures. Botanix explains:
